New drug LY4005130 put to the test in healthy volunteers
NCT ID NCT06690996
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 32 times
Summary
This early-stage study is testing a new drug, LY4005130, in 118 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo, given as a shot under the skin or into a vein. The study tracks side effects and drug levels in the blood over several weeks. Because it involves healthy people and focuses on safety, it does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
Conditions
Explore the condition pages connected to this study.